Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Invested Capital (2018 - 2024)

Historic Return on Invested Capital for Assembly Biosciences (ASMB) over the last 6 years, with Q3 2025 value amounting to 0.43%.

  • Assembly Biosciences' Return on Invested Capital rose 11200.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 11200.0%. This contributed to the annual value of 1.23% for FY2024, which is 1800.0% down from last year.
  • Latest data reveals that Assembly Biosciences reported Return on Invested Capital of 0.43% as of Q3 2025, which was up 11200.0% from 1.94% recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Return on Invested Capital peaked at 0.43% during Q3 2025, and registered a low of 2.36% during Q3 2023.
  • Over the past 3 years, Assembly Biosciences' median Return on Invested Capital value was 1.55% (recorded in 2024), while the average stood at 1.6%.
  • Over the last 5 years, Assembly Biosciences' Return on Invested Capital had its largest YoY gain of 11200bps in 2025, and its largest YoY loss of -4200bps in 2025.
  • Assembly Biosciences' Return on Invested Capital (Quarter) stood at 1.54% in 2023, then dropped by 0bps to 1.54% in 2024, then surged by 72bps to 0.43% in 2025.
  • Its Return on Invested Capital stands at 0.43% for Q3 2025, versus 1.94% for Q2 2025 and 1.54% for Q4 2024.